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ORIGINAL ARTICLE
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ABSTRACT
Objectives. During aortic and cardiac surgery, risks for mortality and morbidity are inevitable. Surgical
setups involving deep hypothermic circulatory arrest (DHCA) are effective to achieve organ protection
against ischemic injury. The aim of this study was to identify humoural factors mediating additive pro-
tective effects of remote ischemic preconditioning (RIPC) in a porcine model of DHCA. Design. Twenty-
two pigs were randomized into the RIPC group (n¼ 11) and the control group (n¼ 11). The RIPC group
underwent four 5-minute hind limb ischemia-reperfusion cycles prior to cardiopulmonary bypass and
DHCA. All animals underwent identical surgical procedures including 60min DHCA at 18 C. Blood sam-
ples were collected from vena cava and sagittal sinus at several time points. After the 8-hour follow-up
period, the brain, heart, and kidney tissue samples were collected for tissue analyses. Results. Serum
levels of brain damage marker S100B recovered faster in the RIPC group, after 4 hours of the arrest,
(p< .05). Systemic lactate levels were lower and cardiac index was higher in the RIPC group postopera-
tively. Immunohistochemical cerebellum regional scores of antioxidant response regulator Nrf2 were
better in the RIPC group (mean: 1.1, IQR: 0.0–2.5) compared with the control group (mean: 0.0, IQR:
0.0–0.0), reaching borderline statistical significance (p¼ .064). RIPC induced detectable modulations of
plasma proteome and metabolites. Conclusions. The faster recovery of S100B, lower systemic lactate
levels and favourable regional antioxidant response suggest possible neuronal cellular and mitochon-
drial protection by RIPC, whereas better cardiac index underlines functional effects of RIPC. The exact
humoural factor remains unclear.
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Deep hypothermic circulatory arrest (DHCA) is a widely
used operative technique in the surgical procedures of aortic
pathologies requiring the cessation of the blood supply. For
instance, this method is used in the surgical repair of acute
type A aortic dissection, congenital heart defects, and thora-
coabdominal aortic aneurysms [1–3]. The cerebral protec-
tion of this technique is based on the suppression of the
central nervous system (CNS) metabolic demand increasing
neuronal ischemic tolerance [4,5]. In spite of the hypother-
mic neuroprotection, postoperative mortality of 2.4% to
6.3% and a neurological deficit of 1.6% to 4.8% still exist in
reported series using DHCA, establishing adjunctive protect-
ive strategies to be studied [2,6].
Ischemic preconditioning was first introduced in a canine
model, with an intermittent occlusion of the left circumflex
artery (LCX) prior to prolonged occlusion of LCX, limiting
myocardial infarct size [7]. This preconditioning method,
exposing target tissue to an ischemic stimulus providing
protection against subsequent more severe insult, was later
found to be similarly effective when applied at a distance
along with another nontarget tissue [8,9]. Consequently, car-
dio- and neuroprotective effects of remote ischemic precon-
ditioning (RIPC) have been widely studied both in
experimental and in clinical settings [10–14].
The protective effects of RIPC are well documented
among different mammalian species; however, the underly-
ing molecular mechanisms involved in this protection
remain largely unclear. At present, there are three theories:
the humoural, the neural, and the systemic [15]. The largest
body of preclinical data supports the concept of an RIPC-
induced factor(s) in the bloodstream that conveys protection
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from the transiently ischemic limb to the remote organ(s)
[16–22]. Moreover, the preconditioning protection has been
shown to be transferable with the plasma, even in cases of
cross-species transfer [17,18,23,24] and it appeared to be
mediated via a small, unknown hydrophobic factor under
30 kDa [17,25].
Oxidative stress, imbalance between the production of
reactive oxygen species (ROS) and antioxidant defence sys-
tem, and especially restricted production of ROS are consid-
ered one of the possible mechanisms behind the
preconditioning phenomenon [26]. One of the key antioxi-
dant response regulators, nuclear factor erythroid 2-related
factor, Nrf2, senses the cellular redox status [27]. Ischemia-
reperfusion stimulus, low production of ROS, and conse-
quently mild oxidative stress, induce the translocation of
Nrf2 from cytoplasm to nucleus, leading to the induction of
various antioxidant enzymes.
Moreover, it was recently reported that preconditioning
via inhibition of EGLN1, a hypoxia-inducible factor (HIF)
prolyl 4-hydroxylase, in skeletal muscle reroutes a-ketogluta-
rate (aKG), which drives hepatic production and secretion
of kynurenic acid (KYNA) that is necessary and sufficient to
mediate cardiac ischemic protection in mice [28].
The objective of the study was to assess the additive pro-
tective effects of RIPC and identify different humoural circu-
lating factors mediating the mechanisms of RIPC in a
porcine model of DHCA.
Materials and methods
Experimental setup
Twenty-two female pigs from a native stock (aged 7–8
weeks) were randomized into two groups, a control group
(n¼ 11) and a remote ischemic preconditioning (RIPC)
group (n¼ 11) using sealed envelopes. All animals under-
went 60minutes of deep hypothermic circulatory arrest at
18 C. In advance of cardiopulmonary bypass (CPB) proce-
dures, the RIPC group underwent 4 cycles of 5-minute right
hind limb ischemia-reperfusion episodes. Schematic repre-
sentation of the experimental setup and sampling is shown
in the Figure 1.
All animals received humane care in accordance with the
Principles of Laboratory Animal Care formulated by the
National Society for Medical Research and the Guide for the
Care and Use of Laboratory Animals prepared by the
Institute of Laboratory Animal Resources, National Resource
Council (Published by National Academy Press, revised
1996). The study protocol was approved by the Research
Animal Care and Use Committee of the University of Oulu.
Anesthesia and cardiopulmonary bypass protocols
The anesthesia, hemodynamic and cardiopulmonary bypass
protocols are described in detail in the online version,
Supplementary Material.
Cranial procedures
A cranial window (35 35mm) was extracted on top of the
scalp using a 14/11mm disposable cranial perforator (200-253
DGR-II, Acra Cut Inc, Acton MA). A peripheral venous can-
nula (22G 25mm BD VenflonTM Peripheral IV Catheter
with Injection port) for blood sampling was inserted through
dura mater to the sagittal sinus and secured thoroughly.
Remote ischemic preconditioning (RIPC)
In remote ischemic preconditioning, a children’s blood pres-
sure cuff was placed around the right hind limb. The cuff
Figure 1. Experimental setup with samplings. BL: baseline time point; CBP: cardiopulmonary bypass; CO20: cooling 20minutes time point; EX: exitus time point;
HCA: hypothermic circulatory arrest; PAR: postarrest time period; PR: postintervention time point; RIPC: remote ischemic preconditioning; W: warming time period;
W5: rewarming phase after arrest time point.
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was inflated to >250mmHg for 5minutes followed by a 5-
minute deflation. This intermittent ischemia-reperfusion
cycle was repeated four times, and the total time of RIPC
stimulus lasted for 40minutes, as in previous studies [7,10].
In the control group the blood pressure cuff was placed for
40minutes around the right hind limd without any infla-
tion-deflation cycles. Preconditioning was performed
65minutes (IQR: 51–72minutes, p¼ .752) prior to CPB, and
hypothermic circulatory arrest was achieved 95minutes from
the last preconditioning cycle targeting for the first protect-
ive window of RIPC [29].
Postoperative management
Intravenous noradrenalin infusion was used postoperatively
if necessary to maintain mean arterial pressure over
60mmHg. Animals were under terminal anesthesia, which
together with mechanical ventilation were maintained for
8 hours after DHCA followed by euthanization using pento-
barbital (90mg/kg).
Sample collection and biochemical data
Cardiac output, pulmonary capillary wedge pressure, urine
volume, infused fluid volume, and inotropes administered,
as well as rectal and pulmonary artery temperature readings,
were recorded. Blood count, cardiac troponin I (TnI), creat-
ine kinase isoenzyme MB (CK-MBm), blood gas values, pH,
electrolytes, serum ionized calcium, plasma lactate levels,
venous glucose, hematocrit, and hemoglobin levels (iSTAT
Analyzer; iSTAT Corporation, East Windsor, NJ) were
measured at baseline (BL), at the end of the remote ischemic
preconditioning or sham treatment (PR), after 20minutes of
cooling (CO20), at 5minutes (W5), and 1, 2, 4, 8 hours
from the end of the DHCA.
Collection of blood and isolation of serum samples from
vena cava and sagittal sinus
Blood samples were collected from two different vessels,
vena cava (VC) and sagittal sinus (SS), at the aforemen-
tioned time points. The proteomics analyses were carried
out in the Proteomics core facility at Karolinska Institute,
Stockholm, Sweden. The exact preparation of protein extrac-
tion and solubilization, in solution digestion, PRLC-MS/MS
analysis, data processing, protein quantitation and ELISA
are described in detail in the online version, Supplementary
Material.
Protein biomarker for brain damage
Serum S100B levels were analysed with ELISA kit (Fujirebio
Diagnostics) following the manufacturer’s instructions.
Analysis of KYNA and aKG levels
The KYNA and aKG levels in serum were analyzed as in
Olenchock et al. 2016 [28].
Histopathological analysis and immunohistochemistry
After euthanization, the tissue samples were collected from
the brain, the right ventricle of the heart and the right kid-
ney and fixed in 10% formalin solution. The preparation
methods and scoring systems of histopathological and
immunohistochemical analyses are described in the online
version, Supplementary Material.
Statistical analysis
SPSS (version 22.0; SPSS Inc, Chicago, IL) and SAS (version
9.3; SAS Institute, Cary, NC) statistical software packages
were used for statistical analysis. Continuous and ordinal
variables are expressed as the median with interquartile
range (IQR; 25th and 75th percentiles). In the figures, mean
and standard error of mean (SEM) are used. Complete inde-
pendence was assumed across all animals (by random state-
ment). Distribution of the variable was tested using the
Shapiro-Wilks test of normality. Either the Student t test or
Mann-Whitney U test was used to assess the p values
between the variables of the study groups. Two-tailed signifi-
cance levels are reported. p .05 was considered statistically
significant. In the proteomics analysis of serum samples,
non-parametric statistic tests, Friedman and Dunn’s multiple
comparison tests, were used to detect differences across mul-
tiple sample populations.
The repeatedly measured data was analyzed using a linear
mixed model with animals fitted as random, and the covari-
ance pattern was chosen according to Akaike’s Information
Criterion. Reported p values are as follows: p between
groups (pg) indicates a level of difference between the
groups; p for time by group (ptg) indicates behaviour
between the groups with time.
Results
Mortality
A total of 22 animals were operated on. Six animals were
excluded from the analyses. Four animals were lost during
the sagittal sinus or aortic cannulations. One animal from
each study group was lost during the follow-up period due
to acute heart failure. Eventually, 16 animals were included
in the final analysis.
Comparability of study groups
The mean weight of the pigs in the control group was
19.1 kg and in the RIPC group 20.0 kg (p¼ .316). The
amount of transfused blood was 69.0ml/kg (62.5–78.6ml/kg)
in the intervention group and 68.7ml/kg (62.3–74.4ml/kg) in
the control group, respectively (p¼ .767).
Experimental and metabolic data
Systemic concentration of venous lactate was lower in the
intervention group after the operation, and the baseline level
was more rapidly reached in the RIPC group (Figure 2(A)).
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After weaning from the CPB, the RIPC group also demon-
strated a better cardiac index reaching the baseline values
(Figure 2(B)). The study groups did not differ in number of
defibrillations (p¼ .494), the usage of noradrenaline need
for inotropes after the operation (p¼ .643), or fluid balance
at the end of the follow-up (p¼ .987). Experimental and
metabolic data are summarized in the online version,
Supplementary Tables 2(A, B).
Neurological markers
The serum levels of S100B protein changed in a similar
manner during the surgery in both groups. S100B protein
levels peaked after DHCA during the initial rewarming
phase and slowly decreased to baseline during the follow-up
period in the control group. However, the serum levels of
S100B protein declined faster in the RIPC group, reaching a
significant difference compared with the control group at
4 hours after the arrest (Figure 3).
Proteomics analysis of serum samples
In the online version, Supplementary Table 1 shows all
serum samples analysed and identification of peptides and
proteins per sample. The number of proteins detected trust-
worthy was relatively low in all samples. This could be due
to using sera non-depleted from major proteins, as well as
the limited number of identified porcine proteins in the
public databases. The samples from VC and SS were com-
pared to the baseline from the corresponding vessel, and
change of 20% in abundance was set as a threshold. From
all reliably detected proteins in samples, 57 (42%) were
known porcine proteins, while 78 (58%) were uncharacter-
ized (Supplementary Table 1). The identified changes in pro-
tein levels in the control and RIPC groups in the indicated
time points is presented in Figure 4.
Next, we used an open-source bioinformatics gene ana-
lysis tool (PANTHER) to map the biological processes these
proteins are involved in. The known proteins were related
to variety of biological processes such as metabolic, cellular,
development, and immune system processes, and localiza-
tion (Figure 5).
Particular interest was given to samples from sagittal
sinus because they were taken behind the blood-brain bar-
rier. Based on previous literature on protein functions and
possible relevance to RIPC [19,21,30] we selected 4 proteins:,
apolipoprotein E (APOE), complement C3 (C3), transthyre-
tin (TTR) and vitronectin (VTN), to be validated by ELISA.
The levels of these four proteins were, however, not signifi-
cantly changed between the RIPC and control groups at any
of the studied time points (Figure 6).
Analysis of serum KYNA and aKG levels
The levels of aKG in the vena cava samples decreased sig-
nificantly following the first and third cycle of ischemia-
reperfusion with consistent oscillations in metabolite
levels seen in all experimental animals (Figure 7) [28].
Figure 3. Serum concentration of S100B at different time points of the surgery.
BL: baseline time point; HCA: hypothermic circulatory arrest; PR: postinterven-
tion time point; S100B: glial-specific S100 calcium binding protein B; W5:
rewarming phase after arrest time point. Mean ± SEM is presented. p< .05 at
specific time point. Student t test.
Figure 2. Systemic concentration of lactate (2A). Cardiac index (2B). CO20: cooling 20minutes time point; HCA: hypothermic circulatory arrest; PR: postintervention
time point; RIPC: remote ischemic preconditioning; W5: rewarming phase after arrest time point. Mean ± SEM is presented. p< .05, þp< .06 at specific time point.
Mann-Whitney U test.
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Figure 4. Changed recognized porcine proteins at different time points of the HCA surgery. (A) VC_PR vs BL, (B) VC_W5 vs BL, (C) SS_PR vs BL, (D) SS_W5 vs BL.
For analysis of the difference in expression change of >20% was set as a treshold. BL: baseline time point; HCA: hypothermic circulatory arrest; PR: postintervention
time point; SS: sagittal sinus; VC: vena cava; W5: rewarming phase after arrest time point.
Figure 5. Pie chart representation of the biological functions of the known serum proteins using the PANTHER software. PR: postintervention time point; SS: sagittal
sinus; VC: vena cava; W5: rewarming phase after arrest time point.
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No significant change in aKG were seen in the sagittal sinus
samples following RIPC. KYNA levels were variable among
animals, and levels did not change significantly in either the
sagittal sinus or vena cava.
Histopathology and immunohistochemistry
The total histopathological sum score of CNS did not differ
between the study groups (p¼ .854). The most defining
finding was edema in both study groups (p¼ .764).
Haemorrhages were observed only in the control group, but
this difference did not reach a statistically significant differ-
ence between the groups (p¼ .317). Neuronal damage score
did not differ between groups (p¼ .890). There were no
infarction areas detected in the study groups.
In CNS, the total immunohistochemical sum scores of
caspase 3 (p¼ .622) or Nrf2 (p¼ .583) did not differ
between the study groups. The regional differences of the
cytoplasmic Nrf2 scores were detected in the hippocampus
and the cerebellum. In the cerebellum, the cytoplasmic Nrf2
scores were near-significantly higher in the RIPC group
(Mean: 1.1, IQR: 0.0–2.5) compared with the control group
(Mean: 0, IQR: 0.0–0.0), (p¼ .064) (Tables 1A and 1B).
Discussion
Postoperative mortality and neurological deficit remain the
most serious complications related to the surgical repair of
complex aortic and cardiac conditions. The operative
technique of DHCA offers brain protective action,
though further adjunctive methods are still required [2].
Clinically relevant experimental models match to this
demand to develop protective strategies and assess their
effectiveness and underlying mechanisms.
Encouraging experimental results concerning RIPC as a
protective method reducing ischemia-reperfusion injury
have been introduced to clinical settings in past years.
However, in cardiac surgery, recently published results of
two large, multicentre, randomized, controlled trials,
ERICCA and RIPheart, failed to underline these previous
results, indicating that the detection of the underlying pro-
tective mechanism requires further actions and understand-
ing together with the considerations of the suitable patients
and clinical settings to be utilised [13,14].
In this study, the functional effect of RIPC was detected
as a better cardiac index after weaning from the CPB in the
intervention group (Figure 2(B)). The surgical setting itself,
including manipulation of the heart and DHCA, explains
the release of the cardiac enzymes in both groups. The lower
lactate levels in the RIPC group indicate better surveillance
under hypoxic conditions and indirectly better cellular and
mitochondrial function (Figure 2(A)). Furthermore, better
neurological outcome is associated with lower lactate levels
[31]. Additionally, the serum levels of S100B protein
declined faster to the baseline in the RIPC group, suggesting
better tolerance against ischemic insult of DHCA (Figure 3)
[10,32]. The possibility of extracerebral release of S100B
needs to be taken into account [33,34]. However, the surgi-
cal trauma was identical for both study groups, as well as
cardiotomy suction blood was not used targeting the release
of S100B from the cerebral injury in the serum analysis [34].
During ischemia, Nrf2 expression is associated with neur-
onal cell protection [35]. Cytoplasmic Nrf2 staining reaction
Figure 6. Sagittal sinus serum concentration of vitronectin (VTR), transthyretin (TTR), complement C3 (C3), and apolipoprotein E (ApoE) at baseline (BL), postinter-
vention (PR), and rewarming phase after HCA (W5) in control (n: 8) and RIPC (n: 8) groups. BL: baseline time point; HCA: hypothermic circulatory arrest; PR: postin-
tervention time point; RIPC: remote ischemic preconditioning; W5: rewarming phase after arrest time point. Mean ± SEM is presented.
Figure 7. The behavior of serum (vena cava, VC) and sagittal sinus (SS) levels of aKG and KYNA during ischemia-reperfusion cycles in the RIPC group. aKG: alpha-
ketoglutarate; KYNA: kynurenic acid; RIPC: remote ischemic preconditioning; SS: sagittal sinus; TIC: total ion chromatogram.
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was in favour of the RIPC group in the cerebellum, indicat-
ing better neuronal cell protection against oxidative stress
(Table 1(A)). Expression of caspase 3 is associated with the
induction of DNA fragmentation and the activation of apop-
tosis [36]. Different grades of apoptotic events occurred in
both study groups according to the caspase 3 findings.
Limitations of this study, including a short follow-up period
and a small group size, can partly explain the modest results
of hematoxylin-eosin stainings.
Levels of aKG decline in vena cava samples following
RIPC, opposite to the accumulation seen following pharma-
cologic or genetic inhibition of EGLN1 in mice [28]. The
activity of HIF prolyl 4-hydroxylases would be anticipated to
decrease during ischemia and then increase during reperfu-
sion in our ischemia-reperfusion model, which would not be
the case following gene deletion or pharmacologic inhibitor
studies. In support of this, we were unable to detect HIF1a
protein stabilization in muscle extracts (data not shown). It
is possible that oscillations of aKG levels seen in our study
reflect repeated changes in EGLN1 activity, but further work
would be needed to test this hypothesis. Additionally, no
change in KYNA levels were seen in our study. Differences
in model organism or differences between pseudohypoxia
and ischemia likely contribute to this difference in KYNA
and aKG levels between our studies and prior work [28].
The proteomics analyses on sera from vena cava and
sagittal sinus at two different time points of DHCA surgery
althogether displayed 18 known porcine proteins, which
appeared differentially expressed in response to the RIPC
protocol compared with baseline and/or control values
(Figures 4 and 5). All identified known porcine proteins
were blood “residents” [37]. In addition to common blood
circulating proteins (APOC3, APOE, HBB), the identified
proteins also included coagulation or complement factors
(F5, C3, C7), transport proteins (HBA, TTR, CBG) and
other secreted and extracellular proteins (VTN, FGB,
FBLN1, LAC, PGLYRP2, PC, IGFALS, A1BG). The identi-
fied proteins play a role in a range of biological processes
(PANTHER) (Figure 5), suggesting that the RIPC-mediated
neuroprotective mechanism(s) during DHCA in porcine
model probably involve complex synergy between different
signaling pathways.
Specific attention was given to porcine proteins putatively
relevant for RIPC protection (19–20, 314), namely APOE,
C3, TTR, and VTN, in the sagittal sinus blood samples. Our
results showed, however, no significant changes in their con-
centration between the RIPC and control group at any time
point (Figure 6), suggesting that those proteins were likely
not involved in mediating the protective effects of RIPC in
that particular time-frame of DHCA surgical protocol. Due
to the limited number of annotated porcine proteins in the
public databases, identification of >50% of the detected pro-
teins was impossible. Therefore, we cannot exclude the pos-
sibility that these so far uncharacterized proteins contributed
to the remote ischemic preconditioning.
Conclusions
The faster recovery of serum S100B levels suggests better
ischemic tolerance by the brain of RIPC. The lower systemic
lactate suggests better cellular and mitochondrial function
after global ischemia in the RIPC group. The higher regional
cytoplasmic Nrf2 scores indicate possible favourable neur-
onal cell protection against oxidative stress in the RIPC
group. Similarly, the better cardiac index signifies functional
effects of RIPC postoperatively.
Table 1A. Immunohistochemistry.
Cortex Thalamus Hippocampus Brainstem Cerebellum Total
Protocol Immunostaining Score Score Score Score Score Score
RIPC mean Caspase 3
(Nucleus)
5.6 (5.3–6.0) 4.4 (4.0–5.0) 5.5 (5.0–6.0) 5.4 (5.0–6.0) 4.6 (4.0–5.0) 25.5 (24.3–27.0)
Control mean 5.6 (5.3–6.0) 4.3 (3.5–5.0) 5.6 (5.5–6.0) 4.9 (4.0–6.0) 3.9 (3.5–4.5) 25.0 (23.0–26.0)
p-value .727 .883 .593 .281 .138 .622
RIPC mean Nrf2
(Cytoplasm)
0.6 (0.0–1.0) 0.0 (0.0–0.0) 3.4 (1.5–5.0) 1.9 (0.0–4.5) 1.1 (0.0–2.5) 6.9 (4.5–9.3)
Control mean 0.6 (0.0–1.0) 1.0 (0.0–2.0) 5.1 (4.5–6.0) 1.0 (0.0–2.0) 0.0 (0.0–0.0) 8.1 (5.0–10.0)
p-value 1.000 .143 .084 .442 .064 .583
RIPC n¼ 8, Control n¼ 8. Immunohistochemical data after the 8-hour follow-up. Score; mean (IQR; 25th and 75th percentiles).
IQR: interquartile range; Nrf2: nuclear factor erythroid 2-related factor 2; RIPC: remote ischemic preconditioning.
Table 1B. Immunohistochemistry.
Kidney (glomerulus) Kidney (tubular cells) Heart
Protocol Immunostaining Score Score Score
RIPC mean Caspase 3
(Nucleus)
5.8 (6.0–6.0) 6.0 (6.0–6.0) 5.8 (5.5–6.0)
Control mean 5.1 (4.0–6.0) 6.0 (6.0–6.0) 5.8 (5.5–6.0)
p-value .239 1.000 1.000
RIPC mean Nrf2
(Cytoplasm)
2.9 (0.0–5.0) 3.6 (2.0–5.0) 4.0 (3.5–4.5)
Control mean 2.4 (0.0–5.0) 2.0 (0.0–5.0) 3.9 (1.5–6.0)
p-value .777 .358 .592
RIPC n¼ 8, Control n¼ 8. Immunohistochemical data after the 8-hour follow-up. Score; mean (IQR; 25th and 75th percentiles).
IQR: interquartile range; Nrf2: nuclear factor erythroid 2-related factor 2; RIPC: remote ischemic preconditioning.
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We were not able to identify any specific protein media-
ting the effect of RIPC. However, the RIPC-induced effectors
do not necessarily have to be proteins. They could be circu-
lating metabolites, non-peptide hormones or combinations
of several factors. Therefore, additional and more analytic-
ally deepened research needs to be carried out to identify
global changes in peptides, non-peptide hormones, and
other metabolites following the RIPC protocol.
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